ROVI Archives

Aprobación de Okedi® para esquizofrenia

ROVI recibe la aprobación de la Comisión Europea para Okedi® como tratamiento de la esquizofrenia La Comisión Europea ha autorizado

La farmacéutica incrementa sus ingresos operativos un 26% y un 30% su beneficio neto Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI),

La alta capacidad de fabricación y diferenciada tecnología disponible en sus instalaciones, permite a ROVI dar respuesta a la creciente

Cookie	Duración	Descripción
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.